Replies to post #209322 on NorthWest Biotherapeutics Inc (NWBO)

[Sojourner55]

In the past, they have responded to shareholder enquiries through an 8K. To ensure public dissemination they may choose to do so again with carefully parsed responses, rather than a PR so no twisting of words or intent by AF and his gang. If they do that, then we will probably have a lively ASM. I'm not counting on new info at LP's presentation but would be pleasantly surprised if she did. The one piece of info she could share is the number of survivors as of Nov since they did publish that in 2017.

[Poor Man -]

This would be a leopard changing its spots.

I know of an influential investor that has pushed for greater transparency, but we'll see. Previous ASMs appear designed to limit information, while controlling Q&A.

Ideally, they receive questions ahead of ASM and have an opportunity to provide public responses prior to the ASM. Then we can ask why they have decided to not address other questions that were asked.

It may be good to articulate the desire to provide public responses to these questions ahead of the ASM so they can further discuss the questions at the ASM.